Clinical Trial Update: A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating the safety and effects of the RNA vaccine ARCT-021 in healthy adults. The study was terminated and results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars

Drugs mentioned

• ARCT-021

Snippet

Sponsor: Arcturus Therapeutics, Inc. | Conditions: Covid19, SARS-CoV Infection | Phase 2 | Status: TERMINATED | Results posted: 2025-05-15